Inhibiting store-operated calcium entry attenuates white matter secondary degeneration following SCI

Ben C Orem1, Steven B Partain2, David P Stirling3

  • 1Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, KY 40202, USA; Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, KY 40202, USA.

Neurobiology of Disease
|December 18, 2019
PubMed

Insights

Blocking store-operated calcium entry reduces secondary damage after spinal cord injury. This novel therapeutic target lessens axonal degeneration and promotes oligodendrocyte survival, offering neuroprotection in preclinical models.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Axonal degeneration is a critical factor in neurological disorders like spinal cord injury (SCI).
  • Secondary degeneration expands lesion size after initial trauma.
  • Store-operated calcium entry (SOCE) is implicated in various disorders, but its role in SCI is unclear.

Purpose of the Study:

  • To investigate the role of SOCE in secondary white matter degeneration after SCI.
  • To determine if inhibiting SOCE is neuroprotective following SCI.

Main Methods:

  • Utilized a laser-induced SCI model in murine spinal cord preparations to study axonal changes.
  • Administered YM-58483, a SOCE inhibitor, and observed effects on axonal degeneration and calcium levels using two-photon microscopy.
  • Applied YM-58483 in a clinically relevant contusion SCI model in vivo to assess axonal survival and spheroid formation.

Main Results:

  • Delayed YM-58483 treatment significantly reduced intra-axonal calcium, axonal dieback, and bystander damage in the laser-SCI model.
  • Inhibition of SOCE promoted oligodendrocyte survival post-injury.
  • In vivo, YM-58483 treatment increased axonal survival and decreased spheroid formation in the contusion SCI model.

Conclusions:

  • Store-operated calcium entry mediates secondary white matter degeneration after spinal cord injury.
  • Acute inhibition of SOCE is neuroprotective, reducing axonal damage and improving survival.
  • Targeting SOCE represents a novel therapeutic strategy for preventing pathological calcium influx in SCI.